Ralph Brandenberger - Jun 2, 2021 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Signature
/s/ Alicia Hager, as Attorney-in-Fact
Stock symbol
NKTX
Transactions as of
Jun 2, 2021
Transactions value $
-$86,152
Form type
4
Date filed
6/4/2021, 02:29 PM
Next filing
Sep 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTX Common Stock Options Exercise $139 +340 $0.41* 340 Jun 2, 2021 Direct F1
transaction NKTX Common Stock Options Exercise $1.93K +405 +119.12% $4.77 745 Jun 2, 2021 Direct F1
transaction NKTX Common Stock Options Exercise $5.28K +1.36K +182.28% $3.89 2.1K Jun 2, 2021 Direct F1
transaction NKTX Common Stock Options Exercise $7.92K +2.04K +96.86% $3.89 4.14K Jun 2, 2021 Direct F1
transaction NKTX Common Stock Sale -$101K -4.14K -100% $24.50* 0 Jun 2, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTX Stock Option (right to buy) Options Exercise $0 -340 -3.9% $0.00 8.39K Jun 2, 2021 Common Stock 340 $0.41 Direct F1, F2
transaction NKTX Stock Option (right to buy) Options Exercise $0 -405 -3.89% $0.00 10K Jun 2, 2021 Common Stock 405 $4.77 Direct F1, F3
transaction NKTX Stock Option (right to buy) Options Exercise $0 -1.36K -3.9% $0.00 33.5K Jun 2, 2021 Common Stock 1.36K $3.89 Direct F1, F4
transaction NKTX Stock Option (right to buy) Options Exercise $0 -2.04K -3.9% $0.00 50.3K Jun 2, 2021 Common Stock 2.04K $3.89 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
F2 The option is vested and exercisable as to 6,498 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022.
F3 The option is vested and exercisable as to 5,721 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.
F4 The option is vested and exercisable as to 5,583 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.
F5 The option is vested and exercisable as to 18,561 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.

Remarks:

Sr. VP, Technical Operations